Patents by Inventor Runye H. Zha

Runye H. Zha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-angiogenic molecules, nanostructures and uses thereof
    Patent number: 9556232
    Abstract: The disclosure is generally directed toward the design and synthesis of peptide amphiphile (PA) molecules that comprises a peptide configured to inhibit angiogenesis. The peptide amphiphile comprises a hydrophobic tail, peptide sequence capable of beta-sheet formation; and a peptide, wherein the peptide is configured to inhibit angiogenesis. Optionally the PA further comprises a flexible linker between the peptide sequence capable of beta-sheet formation and the peptides. Further this disclosure is directed to nanostructures comprising peptide amphiphiles configured to inhibit angiogenesis.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: January 31, 2017
    Assignee: Northwestern University
    Inventors: Runye H. Zha, Ming Zhang, Samuel I. Stupp
  • ANTI-ANGIOGENIC MOLECULES, NANOSTRUCTURES AND USES THEREOF
    Publication number: 20160108088
    Abstract: The disclosure is generally directed toward the design and synthesis of peptide amphiphile (PA) molecules that comprises a peptide configured to inhibit angiogenesis. The peptide amphiphile comprises a hydrophobic tail, peptide sequence capable of beta-sheet formation; and a peptide, wherein the peptide is configured to inhibit angiogenesis. Optionally the PA further comprises a flexible linker between the peptide sequence capable of beta-sheet formation and the peptides. Further this disclosure is directed to nanostructures comprising peptide amphiphiles configured to inhibit angiogenesis.
    Type: Application
    Filed: October 27, 2015
    Publication date: April 21, 2016
    Inventors: Runye H. Zha, Ming Zhang, Samuel I. Stupp
  • Anti-angiogenic molecules, nanostructures and uses thereof
    Patent number: 9169294
    Abstract: The disclosure is generally directed toward the design and synthesis of peptide amphiphile (PA) molecules that comprises a peptide configured to inhibit angiogenesis. The peptide amphiphile comprises a hydrophobic tail, peptide sequence capable of beta-sheet formation; and a peptide, wherein the peptide is configured to inhibit angiogenesis. Optionally the PA further comprises a flexible linker between the peptide sequence capable of beta-sheet formation and the peptides. Further this disclosure is directed to nanostructures comprising peptide amphiphiles configured to inhibit angiogenesis.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: October 27, 2015
    Assignee: NORTHWESTERN UNIVERSITY
    Inventors: Runye H. Zha, Ming Zhang, Samuel I. Stupp
  • ANTI-ANGIOGENIC MOLECULES, NANOSTRUCTURES AND USES THEREOF
    Publication number: 20140256635
    Abstract: The disclosure is generally directed toward the design and synthesis of peptide amphiphile (PA) molecules that comprises a peptide configured to inhibit angiogenesis. The peptide amphiphile comprises a hydrophobic tail, peptide sequence capable of beta-sheet formation; and a peptide, wherein the peptide is configured to inhibit angiogenesis. Optionally the PA further comprises a flexible linker between the peptide sequence capable of beta-sheet formation and the peptides. Further this disclosure is directed to nanostructures comprising peptide amphiphiles configured to inhibit angiogenesis.
    Type: Application
    Filed: March 10, 2014
    Publication date: September 11, 2014
    Applicant: Northwestern University
    Inventors: Runye H. Zha, Ming Zhang, Samuel I. Stupp